Want to see JP:4894 full AI Analyst Report?
Cuorips Inc. (4894) Stock Price & Analysis
4894 Stock Chart & Stats
- Day’s Range
- JPY 6,810.00 - JPY 7,100.00
- 52-Week Range
- JPY 3,610.00 - JPY 12,400.00
- Previous Close
- JPY 7,060.00
- Volume
- N/A
- Average Volume (3M)
- 168.28K
- Market Cap
- JPY 62.70B
- Enterprise Value
- JPY 32.41B
- Total Cash (Recent Filing)
- JPY 3.32B
- Total Debt (Recent Filing)
- JPY 0
- Price to Earnings (P/E)
- ―
- Beta
- 0.98
- Next Earnings
- Nov 13, 2026 (Est.)
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Debt-free Balance Sheet
Zero debt removes interest obligations and lowers balance-sheet risk, while sizable equity provides a cushion for ongoing investment. This financial flexibility can help the company sustain operations and pursue development without immediate reliance on borrowing.
Prior Revenue Expansion
The company has demonstrated an ability to expand revenue from its initially small base, indicating that its commercial activities have generated some historical growth. If restored, that prior expansion could support operating leverage and a broader revenue foundation.
Cash Flow Broadly Tracks Losses
Free cash flow tracking net income near one times suggests that reported losses broadly reflect the company’s cash economics rather than being dominated by a major additional cash conversion gap. That alignment improves the interpretability of earnings, even though cash generation remains negative.
Bears Say
Revenue Contraction
The latest annual revenue decline shows that prior growth has not yet translated into a stable upward trajectory. A contraction in sales can reduce operating leverage, weaken investment efficiency, and make it harder for the company to absorb its existing cost base over the next several quarters.
Widening Losses And Margins
Widening losses alongside sharply weaker gross margins indicate deteriorating underlying economics and greater cost intensity. Unless profitability improves, the company may need to devote more capital to supporting each unit of revenue, delaying any path toward sustainable earnings.
Increasing Cash Burn
Persistently negative operating and free cash flow, combined with a larger latest-year outflow, points to substantial ongoing spending requirements. Continued cash burn can increase funding needs and reduce the financial cushion available to support development if losses persist.
4894 FAQ
What was Cuorips Inc.’s price range in the past 12 months?
What is Cuorips Inc.’s market cap?
When is Cuorips Inc.’s upcoming earnings report date?
How were Cuorips Inc.’s earnings last quarter?
Is Cuorips Inc. overvalued?
Does Cuorips Inc. pay dividends?
What is Cuorips Inc.’s EPS estimate?
How many shares outstanding does Cuorips Inc. have?
What happened to Cuorips Inc.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Cuorips Inc.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Cuorips Inc.
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Takayuki Kusanagi
- Employees
- 51
- Website
- cuorips.co.jp
- Address
- Nakanoshima Qross 8F, O-Nexus, Osaka, 530-0005, JP
Cuorips Inc. (4894) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 13 | 6 | 3 |
| Technical Analysis | 3 | 6 | 1 |
| Moving Averages | 10 | 0 | 2 |
